Learning Skills in Shoulder Dystocia Delivery Using Simulator Models

NCT ID: NCT05921045

Last Updated: 2024-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Learning skills on shoulder dystocia on doctor and midwife

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Active learning on mannequin for shoulder dystocia deliveries on doctor and midwife using role play approach and its effect on clinical practice using questionnaires after first training and 6 months training

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Dystocia - Delivered Birth Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

time 0 and 6 months answers

questionnaire answers after first training and after re-training on shoulder dystocia model

modification of clinical approach in clinical practice at time 0

Intervention Type OTHER

evaluation of modification in clinical approach after training

modification of clinical approach in clinical practice at 6 months

Intervention Type OTHER

evaluation of modification in clinical approach after retraining

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

modification of clinical approach in clinical practice at time 0

evaluation of modification in clinical approach after training

Intervention Type OTHER

modification of clinical approach in clinical practice at 6 months

evaluation of modification in clinical approach after retraining

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

questionnaire for evaluation of modification in clinical approach questionnaire for evaluation of modification in clinical approach

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* residents and specialists in obstetrics and gynecology
* midwives

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Claudio Crescini, MD Humanitas Milan Italy

UNKNOWN

Sponsor Role collaborator

Federico Prefumo, Istituto Giannina Gaslini

UNKNOWN

Sponsor Role collaborator

Claudio Meloni, University of Florence

UNKNOWN

Sponsor Role collaborator

G. d'Annunzio University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Claudio Celentano

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudio Celentano, MD

Role: PRINCIPAL_INVESTIGATOR

EASC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Claudio Celentano

Pescara, Italia, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ObGynEASC002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.